Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Home > Búsqueda > au:"Sinvhal, Ranjeeta" (4)

RSS XML

Imprimir

Exportar

Email

|

Resultados 1 - 4 de 4

1 Próxima > >>

1.

Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.

Papp, Kim A; Blauvelt, Andrew; Puig, Lluís; Ohtsuki, Mamitaro; Beissert, Stefan; Gooderham, Melinda; Amin, Ahmad Z; Liu, Jie; Wu, Tianshuang; Azam, Tofial; Stakias, Vassilis; Espaillat, Ramon; Sinvhal, Ranjeeta; Soliman, Ahmed M; Pang, Yinuo; Chen, Michael M; Lebwohl, Mark G.

J Am Acad Dermatol ; 89(6): 1149-1158, 2023 12.

Artículo en Inglés | MEDLINE | ID: mdl-37553030

2.

Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data.

Shear, Neil H; Betts, Keith A; Soliman, Ahmed M; Joshi, Avani; Wang, Yan; Zhao, Jing; Gisondi, Paolo; Sinvhal, Ranjeeta; Armstrong, April W.

J Am Acad Dermatol ; 85(3): 572-581, 2021 09.

Artículo en Inglés | MEDLINE | ID: mdl-33631216

3.

Letter to the editor concerning the article: 'Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA adverse event reporting system (FAERS)'.

Sinvhal, Ranjeeta; Krueger, Whitney S; Kilpatrick, Ryan D; Coppola, Danielle.

Br J Clin Pharmacol ; 89(8): 2639-2641, 2023 08.

Artículo en Inglés | MEDLINE | ID: mdl-37114281

4.

Confounding issues in COPD risk study?

Sinvhal, Ranjeeta; Tosiello, Lorraine; Cable, Greg.

Chest ; 123(1): 307; author reply 307-8, 2003 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-12527640

Resultados 1 - 4 de 4

1 Próxima > >>